Synergy Health Stock Rating Reaffirmed by Canaccord Genuity (SIE)
Synergy Health (LON:SIE)‘s stock had its “sell” rating reaffirmed by analysts at Canaccord Genuity in a research report issued to clients and investors on Thursday, AnalystRatingsNetwork reports. They currently have a GBX 902 ($14.47) price objective on the stock.
Synergy Health (LON:SIE) traded up 1.02% during mid-day trading on Thursday, hitting GBX 90.6395. The stock had a trading volume of 72,254 shares. Synergy Health has a 52 week low of GBX 75.06 and a 52 week high of GBX 88.20. The stock has a 50-day moving average of GBX 8440.69 and a 200-day moving average of GBX 8187.08. The company’s market cap is £76.386 billion.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.